Good Start Genetics grabs $18M in first round
Boston-based Good Start Genetics Inc. has closed on an $18 million Series A round of funding to help the company move its DNA sequencing-based pre-pregnancy genetic test along in development, the company said. Leading the round was OrbiMed Advisors, Safeguard Scientifics Inc. and SV Life Sciences.
At the same time, Good Start named Don Hardison, former COO of Laboratory Corporation of America and CEO of Exact Sciences, as president, CEO and director of the company. Hardison also previously held executive roles at SmithKline Beecham Corp. and Quest Diagnostics Inc.